Clinical Trial Update: Comparing the Safety and Efficacy of Apixaban and Rivaroxaban [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is planned to compare the safety and efficacy of apixaban and rivaroxaban in atrial fibrillation, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Apixaban (apixaban)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Atrial Fibrillation | Phase 4 | Status: NOT_YET_RECRUITING